Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism
- PMID: 39633361
- PMCID: PMC11619250
- DOI: 10.1186/s12933-024-02513-7
Elevated whole blood viscosity is associated with an impaired insulin-stimulated myocardial glucose metabolism
Abstract
Background: Increased whole blood viscosity (WBV) was associated with impaired peripheral glucose metabolism, type 2 diabetes, and cardiovascular disease (CVD). Impaired myocardial glucose metabolism is a risk factor for CVD. Whether an increased WBV is associated with impaired myocardial glucose metabolism is still undefined.
Methods: To elucidate this issue, we evaluated the association between WBV and myocardial glucose metabolic rate (MRGlu) in 57 individuals with different glucose tolerance status. Myocardial MRGlu was assessed using dynamic cardiac 18F-FDG PET combined with euglycemic hyperinsulinemic clamp. WBV was calculated using a validated equation including hematocrit and plasma proteins: WBV = [0.12 × h] + [0.17 × (p - 2.07)], where h is the hematocrit (%) and p the plasma proteins (g/dl). The subjects were stratified into tertiles according to their myocardial MrGlu values.
Results: As compared with individuals in the highest myocardial MrGlu tertile, those in the lowest tertile showed an age-adjusted increase in WBV (5.54 ± 0.3 cP vs. 6.13 ± 0.4 cP respectively; P = 0.001), hematocrit (39.1 ± 3.1% vs. 43.2 ± 3.7% respectively; P = 0.004), and total proteins (7.06 ± 0.3 g/l vs. 7.60 ± 0.3 g/l respectively; P < 0.0001). WBV was negatively correlated with myocardial MRGlu (r = - 0.416, P = 0.001). In a stepwise multivariate regression analysis, including several cardiovascular risk factors, the only variables significantly associated with myocardial MrGlu were WBV (β - 0.505; P < 0.0001), fasting insulin (β - 0.346; P = 0.004), fasting plasma glucose (β - 0.287; P = 0.01), and sex (β 0.280; P = 0.003) explaining the 69.6% of its variation.
Conclusions: The current study showed a strongly association between an increase of WBV and an impaired myocardial glucose metabolism in individuals with a broad spectrum of glucose tolerance.
Keywords: Blood viscosity; Cardiac 18F-FDG PET; Cardiovascular disease; Hematocrit; Insulin resistance; Myocardial glucose metabolism; Type 2 diabetes.
© 2024. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: The study was approved by the Ethics Committee (Comitato Etico Azienda Ospedaliera “Mater Domini”), and informed consent was obtained from each subject in accordance with principles of the Declaration of Helsinki. Consent for publication: Not applicable. Competing interests: The authors declare that they have no competing interests.
Figures
References
-
- Lowe G, Lee A, Rumley A, Price J, Fowkes F. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery study. Br J Haematol. 1997;96:168–73. - PubMed
-
- Irace C, Carallo C, Scavelli F, De Franceschi MS, Esposito T, Gnasso A. Blood viscosity in subjects with normoglycemia and prediabetes. Diabetes Care. 2014;37:488–92. - PubMed
-
- Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Perticone M, Sciacqua A, et al. Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity. Acta Diabetol. 2017;54:775–84. - PubMed
-
- Høieggen A, Fossum E, Moan A, Enger E, Kjeldsen SE. Whole-blood viscosity and the insulin-resistance syndrome. J Hypertens. 1998;16:203–10. - PubMed
-
- Marini MA, Fiorentino TV, Andreozzi F, Mannino GC, Succurro E, Sciacqua A, Mannino GC, Succurro E, Sciacqua A, et al. Hemorheological alterations in adults with prediabetes identified by hemoglobin A1c levels. Nutr Metab Cardiovasc Dis. 2017;27:601–8. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
